Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate LeMaitre Vascular, Inc. before investing.

In this article, we go over a few key elements for understanding LeMaitre Vascular, Inc.’s stock price such as:

• LeMaitre Vascular, Inc.’s current stock price and volume
• Why LeMaitre Vascular, Inc.’s stock price changed recently
• Upgrades and downgrades for LMAT from analysts
• LMAT’s stock price momentum as measured by its relative strength

About LeMaitre Vascular, Inc. (LMAT)

Before we jump into LeMaitre Vascular, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Want to learn more about LeMaitre Vascular, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about LeMaitre Vascular, Inc..

LeMaitre Vascular, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, LeMaitre Vascular, Inc.’s stock price was $101.320.

LeMaitre Vascular, Inc. is down 0.85% from its previous closing price of $102.190.

During the last market session, LeMaitre Vascular, Inc.’s stock traded between $99.310 and $102.100. Currently, there are approximately 22.80 million shares outstanding for LeMaitre Vascular, Inc..

LeMaitre Vascular, Inc.’s price-earnings (P/E) ratio is currently at 37.2, which is high compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

LeMaitre Vascular, Inc. Stock Price History

LeMaitre Vascular, Inc.’s (LMAT) price is currently up 5.59% so far this month.

During the month of July, LeMaitre Vascular, Inc.’s stock price has reached a high of $106.130 and a low of $95.280.

Over the last year, LeMaitre Vascular, Inc. has hit prices as high as $118.010 and as low as $79.005. Year to date, LeMaitre Vascular, Inc.’s stock is up 24.93%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused LeMaitre Vascular, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded LeMaitre Vascular, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate LeMaitre Vascular, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on LeMaitre Vascular, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

LeMaitre Vascular, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about LeMaitre Vascular, Inc. (LMAT) by visiting AAII Stock Evaluator.

Relative Price Strength of LeMaitre Vascular, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, LeMaitre Vascular, Inc. has a weighted four-quarter relative price strength of -0.67%, which translates to a Momentum Score of 50 and is considered to be Average.

Want to learn more about how LeMaitre Vascular, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

LeMaitre Vascular, Inc. Stock Price: Bottom Line

As of July 31, 2026, LeMaitre Vascular, Inc.’s stock price is $101.320, which is down 0.85% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like LeMaitre Vascular, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.